Insider · CIK 0001676905

Johnston Lloyd P.

Reports to the SEC for 1 company · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001676905

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-05	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−3,372 sh	$1.13	−$3,808	265,535
2023-01-05	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−20 sh	$1.11	−$22.208	265,515
2023-01-04	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−6,381 sh	$1.13	−$7,234.14	268,918
2023-01-04	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−11 sh	$1.14	−$12.541	268,907
2023-01-02	RNACCartesian Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+100K sh	—	—	275,299
2023-01-02	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+475K sh	—	—	475,000
2022-01-05	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−3,416 sh	$3.09	−$10.5K	175,299
2022-01-03	RNACCartesian Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+72K sh	—	—	178,715
2022-01-03	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+340K sh	—	—	340,000
2021-12-10	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−4,370 sh	$2.99	−$13.1K	106,715
2021-12-08	RNACCartesian Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+13.8K sh	—	—	111,085
2021-10-13	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−3,892 sh	$4.39	−$17.1K	97,335
2021-10-01	RNACCartesian Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+13.8K sh	—	—	101,227
2021-03-17	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−15.1K sh	$4.45	−$67.3K	87,477
2021-02-11	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+44.9K sh	$0.63	+$28.3K	102,605
2021-02-11	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−44.9K sh	—	—	0
2021-01-04	RNACCartesian Therapeutics, Inc.A Award	Chief Operations Officer	AAward	+38K sh	—	—	57,734
2021-01-04	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+230K sh	—	—	230,000
2020-07-01	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+40K sh	—	—	40,000
2020-01-16	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+5,128 sh	$0.47	+$2,410.16	16,734
2020-01-16	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−5,128 sh	—	—	0
2020-01-02	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+140K sh	—	—	140,000
2019-10-07	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+180K sh	—	—	180,000
2019-07-23	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+10K sh	$0.47	+$4,700	11,606
2019-07-23	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−10K sh	—	—	0
2019-01-07	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+100K sh	$2.60	+$260K	100,000
2018-06-15	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operations Officer	AAward	+50K sh	—	—	50,000
2017-07-07	RNACCartesian Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Operations Officer	AAward	+45K sh	—	—	45,000
2017-07-03	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+5,959 sh	$2.77	+$16.5K	7,565
2017-07-03	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−100 sh	$19.74	−$1,974	7,465
2017-07-03	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−5,859 sh	$19.09	−$112K	1,606
2017-07-03	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−5,959 sh	—	—	126
2017-06-15	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+10.5K sh	$0.47	+$4,940.64	12,118
2017-06-15	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−10.5K sh	$17.04	−$179K	1,606
2017-06-15	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−10.5K sh	—	—	10,000
2017-06-15	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+20.5K sh	$0.47	+$9,640.64	22,118
2017-06-15	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−20.5K sh	$17.00	−$349K	1,606
2017-06-15	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−20.5K sh	—	—	0
2017-04-17	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+13.2K sh	$0.39	+$5,149.95	14,811
2017-04-17	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−13.2K sh	$13.95	−$184K	1,606
2017-04-17	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−13.2K sh	—	—	0
2017-01-23	RNACCartesian Therapeutics, Inc.M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	+15K sh	$0.39	+$5,850	16,606
2017-01-23	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−11.1K sh	$13.95	−$155K	5,496
2017-01-23	RNACCartesian Therapeutics, Inc.S Sale	Chief Operations Officer	SSale	−3,890 sh	$14.17	−$55.1K	1,606
2017-01-23	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	Chief Operations Officer	MExercise/Conversion	−15K sh	—	—	13,205
2016-06-21	RNACCartesian Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	Chief Operations Officer	AAward	+27.6K sh	—	—	27,617

Recent filings

Accepted (ET)
Jan 64
Johnston Lloyd P.0001453687-23-000034
SEC(opens sec.gov)
Jan 44
Johnston Lloyd P.0001453687-23-000019
SEC(opens sec.gov)
Jan 74
Johnston Lloyd P.0001453687-22-000032
SEC(opens sec.gov)
Jan 54
Johnston Lloyd P.0001453687-22-000019
SEC(opens sec.gov)
Dec 144
Johnston Lloyd P.0001453687-21-000184
SEC(opens sec.gov)
Dec 104
Johnston Lloyd P.0001453687-21-000174
SEC(opens sec.gov)
Oct 154
Johnston Lloyd P.0001453687-21-000142
SEC(opens sec.gov)
Oct 54
Johnston Lloyd P.0001453687-21-000133
SEC(opens sec.gov)
Mar 194
Johnston Lloyd P.0001453687-21-000033
SEC(opens sec.gov)
Feb 164
Johnston Lloyd P.0001453687-21-000020
SEC(opens sec.gov)
Jan 64
Johnston Lloyd P.0001453687-21-000016
SEC(opens sec.gov)
Jul 64
Johnston Lloyd P.0001104659-20-081209
SEC(opens sec.gov)
Jan 214
Johnston Lloyd P.0001453687-20-000019
SEC(opens sec.gov)

Companies

Cartesian Therapeutics, Inc.Chief Operations OfficerRNAC

Address

C/O SELECTA BIOSCIENCES, INC. 480 ARSENAL STREET, BUILDING ONE

WATERTOWN, MA, 02472